USA Financial Formulas’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.5K | Sell |
53
-2,841
| -98% | -$662K | ﹤0.01% | 346 |
|
|
2026
Q1 | $707K | Sell |
2,894
-1,582
| -35% | -$368K | 0.13% | 48 |
|
|
2025
Q4 | $926K | Sell |
4,476
-265
| -6% | -$52.4K | 0.17% | 33 |
|
|
2025
Q3 | $879K | Buy |
4,741
+3,032
| +177% | +$519K | 0.15% | 47 |
|
|
2025
Q2 | $261K | Buy |
1,709
+275
| +19% | +$42.3K | 0.04% | 114 |
|
|
2025
Q1 | $238K | Buy |
1,434
+284
| +25% | +$44.4K | 0.04% | 120 |
|
|
2024
Q4 | $166K | Sell |
1,150
-22
| -2% | -$3.41K | 0.03% | 180 |
|
|
2024
Q3 | $190K | Sell |
1,172
-1,165
| -50% | -$186K | 0.03% | 158 |
|
|
2024
Q2 | $342K | Buy |
2,337
+858
| +58% | +$128K | 0.06% | 111 |
|
|
2024
Q1 | $234K | Sell |
1,479
-141
| -9% | -$22.4K | 0.04% | 176 |
|
|
2023
Q4 | $254K | Buy |
1,620
+1,587
| +4,809% | +$243K | 0.04% | 139 |
|
|
2023
Q3 | $5.14K | Hold |
33
| – | – | 0.01% | 248 |
|
|
2023
Q2 | $5.46K | Hold |
33
| – | – | 0.01% | 213 |
|
|
2023
Q1 | $5.12K | Buy |
+33
| New | +$5.33K | 0.01% | 163 |
|
|
2022
Q3 | $10K | Hold |
64
| – | – | 0.02% | 114 |
|
|
2022
Q2 | $11K | Sell |
64
-2
| -3% | -$356 | 0.01% | 139 |
|
|
2022
Q1 | $12K | Sell |
66
-3
| -4% | -$510 | 0.01% | 156 |
|
|
2021
Q4 | $12K | Sell |
69
-5,270
| -99% | -$863K | 0.01% | 187 |
|
|
2021
Q3 | $862K | Sell |
5,339
-460
| -8% | -$78.5K | 0.77% | 65 |
|
|
2021
Q2 | $955K | Sell |
5,799
-2,344
| -29% | -$388K | 0.8% | 59 |
|
|
2021
Q1 | $1.34M | Buy |
8,143
+8,128
| +54,187% | +$1.32M | 1.09% | 18 |
|
|
2020
Q4 | $2K | Sell |
15
-12,859
| -100% | -$1.9M | ﹤0.01% | 232 |
|
|
2020
Q3 | $1.92M | Sell |
12,874
-17,213
| -57% | -$2.55M | 1.45% | 27 |
|
|
2020
Q2 | $4.23M | Buy |
+30,087
| New | +$4.38M | 3.14% | 11 |
|
|
2018
Q1 | – | Sell |
-17,419
| Closed | -$2.43M | – | 356 |
|
|
2017
Q4 | $2.43M | Buy |
+17,419
| New | +$2.43M | 0.58% | 74 |
|
|
2017
Q3 | – | Sell |
-22,963
| Closed | -$3.04M | – | 295 |
|
|
2017
Q2 | $3.04M | Buy |
+22,963
| New | +$2.93M | 0.73% | 48 |
|
|
2016
Q4 | – | Sell |
-120,461
| Closed | -$14.2M | – | 304 |
|
|
2016
Q3 | $14.2M | Sell |
120,461
-2,605
| -2% | -$316K | 3.65% | 2 |
|
|
2016
Q2 | $14.9M | Buy |
+123,066
| New | +$14M | 4.1% | 2 |
|
Other funds holding JNJ
USA Financial Formulas's JNJ Position: Q2 2026 in Review
USA Financial Formulas reduced its Johnson & Johnson (JNJ) stake by 98% in Q2 2026, selling an estimated $662K and leaving 53 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #346.
USA Financial Formulas first reported a position in JNJ in Q2 2016 and has held it in 28 quarters since. The position peaked at $14.9M in Q2 2016. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- USA Financial Formulas held 53 shares of Johnson & Johnson worth $13.5K as of Q2 2026.
- USA Financial Formulas sold 2,841 Johnson & Johnson shares in Q2 2026, an estimated $662K.
- Johnson & Johnson made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #346 holding.
- USA Financial Formulas first reported a position in Johnson & Johnson in Q2 2016 and has held it in 28 quarters since.
- USA Financial Formulas's Johnson & Johnson position peaked at $14.9M in Q2 2016.
- 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.